Ready for your all-in-one single cell sequencing solution?
Contact us
Aging and single cell sequencing
Aging and single cell sequencing

Single Cell Sequencing in Aging Research: A Practical Guide

8’
Protocol and guide

Why Single Cell Resolution Matters in Aging

No individuals age in the same way. And neither do different tissues and cell types. Single cell analysis tells you not only what the individual changes are, but why. For example, Denk et al. (2025) found that urolithin A (UA) supplementation countered age-related immune decline. While flow cytometry analysis identified shifts in immune subpopulations, single cell sequencing identified transcriptomic changes related to T-cell exhaustion, inflammation, and mitochondrial metabolism, suggesting potential mechanisms of the beneficial effect of UA supplementation. This information can help fine-tune healthy longevity strategies.

How Single Cell Sequencing Advances Aging Research

Age is a major risk factor for a wide range of diseases. On the other hand, understanding aging also helps us identify ways to extend healthy longevity, moving from lifespan to healthspan.

Single cell sequencing can be used to measure the hallmarks of aging (López-Otín et al., 2013) at cellular resolution. Here are some typical research questions single cell sequencing has helped to address:

Aging atlases. Building comprehensive cell-type maps of a specific tissue across age. Examples include the Tabula Muris Consortium, or tissue-specific atlases such as mammary glands, muscle, brain, skin, and blood. These are challenging to build given the wide age range and diverse, sometimes hard-to-access tissue types involved, so gaps remain. However, computational tools such as HCATA and HuTAge help researchers explore existing data and narrow down hypotheses.

Transcriptomic pathways and signatures. Single cell analysis helps identify molecular mechanisms of aging and age-related diseases. Mirzac et al. (2025) identified molecular dysregulation in four cell types in Parkinson’s disease (PD), pointing to candidate drug targets. Single cell sequencing also helps identify biomarkers that predict predisposition or populations at risk — Zagare et al. (2025) analyzed PD patient-derived midbrain organoids and identified signatures usable for patient stratification.

Epigenetic changes. Another hallmark of aging. Single cell ATAC-seq (assay for transposase-accessible chromatin using sequencing) measures chromatin accessibility in specific cell types or subpopulations, identifying changes in transcription regulation and how they may correlate with gene expression. For example, sc-ChromAging, a chromatin accessibility-based aging clock built from single cell ATAC-seq data across 401 individuals, identified CD4+ naive T cells as the most accurate age predictor and linked immune aging to inflammation, infection, and tumor-susceptibility pathways (Wei et al., 2026).

Genomic instability. Conventional single cell analysis has been typically limited to the transcriptome, with limited sensitivity for genetic mutation detection. Genomic instability is another hallmark of aging. With targeted panels, it is possible to pick up expressed mutations at high sensitivity, including clonal hematopoiesis of indeterminate potential (CHIP) — age-related somatic mutations that expand clonally in blood stem cells, capturing common CHIP mutations (DNMT3A, TET2, ASXL1, TP53, JAK2) alongside standard transcriptomic output.

RNA turnover. Aging differs not only in what a cell is expressing, but how quickly it’s turning over its transcripts. Aging affects RNA turnover rate independently of steady-state expression level. Using s4U (4-thiouridine) metabolic labeling, it is possible to distinguish newly synthesized RNA from pre-existing transcripts at single cell resolution. In an aging mouse kidney case study, this approach revealed reduced mRNA turnover in aged tissue overall, with young kidney showing markedly more active turnover specifically at the thick ascending limb of the loop of Henle, a level of specificity a standard assay would have missed entirely.

Designing a Single Cell Aging Study  

First, budget and research question

The research question is important. At the same time, since this is a practical guide, we’d like to mention budget as an equally important factor upfront. You have control over your experimental design — you don’t always have control over your budget, which is the real constraint for most researchers.

Atlas work can easily take up hundreds of thousands of dollars in grant funding. Exploratory analyses require a significant number of samples, especially in clinical research where there is large biological variation. Time points (especially in longitudinal studies) and treatment conditions can add up quickly.

A practical way is to divide the project into two phases: a pilot run with limited replicates and groups to identify promising changes, then integrate the data into a larger study that further increases statistical power. This allows you room for adjustment without wasting precious samples and reagents.

Experimental design

Required readout

Readout determines the assay as well as a sample type you can use. Standard transcriptome captures gene expression, but depending on your research question, you may need more, such as chromatin accessibility, immune repertoire, targeted mutation detection, RNA dynamics, full-length RNA, or whole transcriptome analysis.

Once you know your research question type and your budget, the actual experimental design becomes a balance you can adapt to your specific situation. Our statistical power post covers this in more depth.

At this stage, it’s useful to talk to a service provider, who has seen a lot of experiments succeed and fail, and can help provide a sanity check or advice before you commit to anything.

Sample types

Most sample types are now compatible with single cell or single nucleus sequencing, including fresh, frozen, or FFPE samples. There are considerations in selecting one approach versus another. See our scRNA-seq vs. snRNA-seq post and FFPE single cell sequencing for the detailed trade-offs.

Tissue processing

This is the point researchers most often consider too late. Aging tissue, especially tissue with underlying disease or fibrosis, can be difficult to dissociate, and may need protocol optimization. See our tissue dissociation and preservation posts for key considerations and tips.

Data analysis

Think about bioinformatics before starting the project. Besides the standard DEG analysis, typical analyses used for aging-specific studies include trajectory/pseudotime analysis, cell-type-proportion shifts, senescence scoring, and clonal tracing.  

Want to see examples of the use of single cell sequencing in aging research?

Check out our application notes for several case studies in depth.

Download the application note

Single cell sequencing for healthy longevity research

If you’re weighing trade-offs for your specific design, our scientific team is happy to talk it through with you.

Talk to a scientist

Office-Consultation-Discuss-Talk

Talk to a scientist

Drop us a line with your question

Book consultation

References

Angarola, B. L., Sharma, S., Katiyar, N., Kang, H. G., Nehar-Belaid, D., Park, S., Gott, R., Eryilmaz, G. N., LaBarge, M. A., Palucka, K., Chuang, J. H., Korstanje, R., Ucar, D., & Anczuków, O. (2025). Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer. Nature Aging, 5(1), 122–143. https://doi.org/10.1038/s43587-024-00751-8

Bartz, J., Ma, X., Zhang, L., & Dong, X. (2025). Human Cell Aging Transcriptome Atlas (HCATA): A single-cell atlas of age-associated transcriptomic alterations across human tissues. Communications Biology, 8, 1450. https://doi.org/10.1038/s42003-025-08845-8

Denk, D., Singh, A., Kasler, H. G., D’Amico, D., Rey, J., Alcober-Boquet, L., Gorol, J. M., Steup, C., Tiwari, R., Kwok, R., Argüello, R. J., Faitg, J., Sprinzl, K., Zeuzem, S., Nekljudova, V., Loibl, S., Verdin, E., Rinsch, C., & Greten, F. R. (2025). Effect of the mitophagy inducer urolithin A on age-related immune decline: A randomized, placebo-controlled trial. Nature Aging, 5(11), 2309–2322. https://doi.org/10.1038/s43587-025-00996-x

Himori, K., Zhang, B., Hatta, K., & Matsui, Y. (2025). HuTAge: A comprehensive human tissue- and cell-specific ageing signature atlas. Bioinformatics Advances, 5(1), vbaf072. https://doi.org/10.1093/bioadv/vbaf072

Jeffries, A. M., Yu, T., Ziegenfuss, J. S., Tolles, A. K., Baer, C. E., Sotelo, C. B., Kim, Y., Weng, Z., & Lodato, M. A. (2025). Single-cell transcriptomic and genomic changes in the ageing human brain. Nature, 646, 657–666. https://doi.org/10.1038/s41586-025-09435-8

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194–1217. https://doi.org/10.1016/j.cell.2013.05.039

Mirzac, D., Bange, M., Kunz, S., de Jager, P. L., Groppa, S., & Gonzalez-Escamilla, G. (2025). Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s disease. Signal Transduction and Targeted Therapy, 10, 10. https://doi.org/10.1038/s41392-024-02086-7

Perez, K., Ciotlos, S., McGirr, J., Limbad, C., Doi, R., Nederveen, J. P., Nilsson, M. I., Winer, D. A., Evans, W., Tarnopolsky, M., Campisi, J., & Melov, S. (2022). Single nuclei profiling identifies cell specific markers of skeletal muscle aging, frailty, and senescence. Aging, 14(23), 9393–9422. https://doi.org/10.18632/aging.204435

Tabula Muris Consortium. (2020). A single-cell transcriptomic atlas characterizes ageing tissues in the mouse. Nature, 583(7817), 590–595. https://doi.org/10.1038/s41586-020-2496-1

Wei, X., Dong, Y., Lai, H., et al. (2026). sc-ChromAging: A single-cell chromatin accessibility-based clock decodes cell-type-specific epigenetic aging trajectories. npj Aging, 12, 97. https://doi.org/10.1038/s41514-026-00398-2

Zagare, A., Balaur, I., Rougny, A., et al. (2025). Deciphering shared molecular dysregulation across Parkinson’s disease variants using a multi-modal network-based data integration and analysis. npj Parkinson’s Disease, 11, 63. https://doi.org/10.1038/s41531-025-00914-3

Zou, Z., Long, X., Zhao, Q., Zheng, Y., Song, M., Ma, S., Jing, Y., Wang, S., He, Y., Rodriguez Esteban, C., Yu, N., Huang, J., Chan, P., Chen, T., Izpisua Belmonte, J. C., Zhang, W., Qu, J., & Liu, G.-H. (2021). A single-cell transcriptomic atlas of human skin aging. Developmental Cell, 56(3), 383–397. https://doi.org/10.1016/j.devcel.2020.11.002

A post by Yingting Wang

Yingting earned her PhD from the National University of Singapore, specializing in cell biology and tissue engineering. She has eight years of laboratory and commercial experience in single cell multi-omics, including roles in R&D, sales, technical support, and scientific communication.

Check out our latest blog posts

Learn more